Skip to main content
Log in

The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire score as a predictor of skeletal muscle mass loss

  • Short Communication
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Previous studies showed a strong relationship between reduction of appendicular muscle mass and worsening disability; hence, accuracy in assessing muscle mass is considered a key feature for a sarcopenia screening tool.

Aim

The aim of the study was to evaluate if the 7 items of Mini Sarcopenia Risk Assessment (MSRA) questionnaire predict muscle mass loss in a population of community-dwelling elderly subjects over a 5.5-y follow-up.

Methods

The study included 159 subjects, 92 women and 67 men aged 71.5 ± 2.2 years and with mean body mass index of 26.7 ± 4.0 kg/m2. Appendicular skeletal muscle mass (ASMM) as measured with Dual-Energy X-ray absorptiometry (DXA), was obtained at baseline and after 2 and 5.5 years of follow-up where the skeletal muscle index (SMI) was calculated.

Results

A significant reduction of ASMM and SMI was observed at two and 5.5 years of follow-up, in both, men and women. Repeated-measures analysis of variance (ANOVA) found a significant time effect on ASMM for both subjects with MSRA > 30 and ≤ 30 (P < 0.01 and P < 0.001). The group × time interaction was significant (P < 0.001), after even considering separately subjects with normal muscle mass and low muscle mass at baseline (P < 0.05 and P = 0.005). Similar results were obtained for SMI. Considering only the subjects with normal SMI at baseline, subjects with MSRA questionnaire ≤ 30 showed 5.7 (95% CI 1.73–19.03) higher risk of exceeding the low muscle mass threshold.

Conclusion

In a population of community-dwelling elderly men and women, MSRA score of 30 is predictive of a steeper decline in ASMM and SMI and of a higher risk of exceeding the low muscle mass EWGSOP threshold.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Cruz-Jentoft AJ, Bahat G, Bauer JM et al (2018) Sarcopenia: revised European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 48:16–31

    Article  Google Scholar 

  2. Landi F, Cruz-Jentoft AJ, Liperoti R et al (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42:203–209

    Article  Google Scholar 

  3. Peña Ordóñez GG, Bustamante Montes LP, Ramírez Duran N et al (2017) Populations and outcome measures used in ongoing research in sarcopenia. Aging Clin Exp Res 29:695–700

    Article  Google Scholar 

  4. Zhao Y, Zhang Y, Hao Q et al (2019) Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res 31:5–14

    Article  Google Scholar 

  5. Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1106

    Article  Google Scholar 

  6. Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759.

  7. Malmstrom TK, Morley J (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532

    Article  Google Scholar 

  8. Rossi AP, Micciolo R, Rubele S et al (2017) Assessing the Risk of Sarcopenia in the Elderly: The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire. J Nutr Health Aging 21:743–749

    Article  CAS  Google Scholar 

  9. Ming Y, Jing L, Jiaojiao J et al (2018) Comparison of four sarcopenia screening tools in nursing home residents. Aging Clin Exp Res 31:1481–1489

    Google Scholar 

  10. Yang M, Hu X, Xie L et al (2019) Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 20:53–57

    Article  Google Scholar 

  11. Barbosa-Silva TG, Menezes AM, Bielemann RM et al (2016) Enhancing SARC-F improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 17: 1136–1141.

  12. Fantin F, Di Francesco V, Fontana G et al (2007) Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci 62:1375–1381

    Article  Google Scholar 

  13. Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass and quality in odler adults: the Heath, Aging and Body Composition Study. J Gerontol Med Sci 61A:1059–1064

    Article  Google Scholar 

  14. Li M, Kong Y, Chen H et al (2019) Accurancy and prognostic ability of the SARC-F questionnaire and Ishii’s score in the screening of sarcopenia in geriatric inpatients. Braz J Med Biol Res 52:e8204

    Article  Google Scholar 

  15. Shiraishi N, Suzuki Y, Hirose T et al (2015) Predictors of decreased skeletal muscle mass in community-dwelling older adults. J Aging Res Clin Pract 4:74–80

    Google Scholar 

Download references

Acknowledgements

The authors' responsibilities were as follows—AR,SU,SG,MEG,MZ: analysis and interpretation of data and preparation of manuscript, AR,FF,MZ: study concept and design, SU,SG,NN,EZ,GM,FF,VM: acquisition of subjects, collection of data.

Funding

This work was supported by grants from MIUR COFIN 2003 n2003069951_002 and MIUR project 2009KENS9K-002.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea P. Rossi.

Ethics declarations

Conflict of interest

None.

Ethical approval

The study was approved by the Ethical Committee of Verona University (progressive number CE 567 approved June 28th, 1997).

Informed consent

All the participants gave their consent to participate in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossi, A.P., Urbani, S., Gattazzo, S. et al. The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire score as a predictor of skeletal muscle mass loss. Aging Clin Exp Res 33, 2593–2597 (2021). https://doi.org/10.1007/s40520-020-01763-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-020-01763-1

Keywords

Navigation